The overall tone demonstrates strong interest and moderate engagement, with many posts referencing specific efficacy figures such as '90.4%' and comparing Novavax to mRNA vaccines, indicating the discussions are grounded in scientific data. Some posts critically examine the methodology, such as questioning whether the trial was double-blind, which shows deeper engagement, but overall, the impact centers on bolstering confidence in the vaccine's efficacy and safety while exposing some concerns about transparency and data integrity.
AgreementModerate agreement
Most discussions support the study’s findings, emphasizing the vaccine’s high efficacy and safety, but there are some doubts about the study's transparency and methodology.
InterestHigh interest
The majority are highly interested, referencing specific trial data, efficacy percentages, and comparisons to other vaccines, showing engagement with the research.
EngagementModerate engagement
Posts include detailed analyses, citations of scientific articles, and debates on side effects and study design, indicating moderate depth of discussion.
ImpactModerate impact
The conversations reflect an acknowledgment that the findings influence opinions on vaccine safety and effectiveness, though some skepticism remains about data transparency.
Abstract in brief
NVXCoV2373 is a vaccine developed to protect against COVID-19, showing effectiveness in trials outside North America but not yet tested there.
A phase 3 trial in the US and Mexico with nearly 30,000 adults found the vaccine to be about 90% effective in preventing COVID-19, including variants of concern like the Alpha variant.
The vaccine was generally safe, with most side effects being mild or moderate, and it proved highly effective against moderate to severe cases of COVID-19.
May 5, 2025 · 66 likes · 14 shares · 846 followersView post →
GP
Geoffrey Norman Pain
@FluoridePoison · X
Novavax shareholder currently wasting my time promoting the
Jan 19, 2024 · 49 likes · 13 shares · 8,455 followersView post →
HB
Hélène Banoun
@BanounHelene · X
Ces données n'apparaissaient pas dans la publication !
https://t.co/frKJuEWdxd
Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico
Jun 4, 2022 · 46 likes · 21 shares · 84,700 followersView post →
RM
Roger Seheult, MD
@RogerSeheult · X
How is Novavax different from the mRNA vaccines.
A good review:
Novavax Explained Clearly
https://t.co/Ql1SpRXKC7
Nov 4, 2023 · 35 likes · 5 shares · 28,028 followersView post →
DS
Don Ford - The People's Strategist -
@DonEford · X
@RolandSB13 "The primary objective was to determine vaccine efficacy against reverse-transcriptase–polymerase-chain-reaction–confirmed Covid-19 occurring at least 7 days after the second dose."
https://t.co/DXRFUDZpNK
This study only had 14 cases of COVID out of a population of 19k
Nov 27, 2025 · 34 likes · 5 shares · 14,976 followersView post →
HB
Hélène Banoun
@BanounHelene · X
Novavax Myocardites
FDA Novavax juin 2022
Ces données n'apparaissaient pas dans la publication !
Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico
Rapport complet ici
https://t.co/fFA21SOxGG
Jun 4, 2022 · 31 likes · 13 shares · 84,700 followersView post →
Roger Seheult MD explains the Novavax vaccine manufacturing process and examines its efficacy, safety, and effectiveness in preventing COVID-19, including variants, based on recent clinical trials in the US and Mexico.
Dr Christy shares updates on the Novavax vaccine, highlighting its proven safety and 90% effectiveness in preventing COVID-19, including variants. The vaccine uses established technology and has a strong safety record.
RT @DonEford: @RolandSB13 "The primary objective was to determine vaccine efficacy against reverse-transcriptase–polymerase-chain-reaction…
Nov 27, 2025 · 5 shares · 373 followersView post →
DS
Don Ford - The People's Strategist -
@DonEford · X
@RolandSB13 "The primary objective was to determine vaccine efficacy against reverse-transcriptase–polymerase-chain-reaction–confirmed Covid-19 occurring at least 7 days after the second dose."
https://t.co/DXRFUDZpNK
This study only had 14 cases of COVID out of a population of 19k
Nov 27, 2025 · 34 likes · 5 shares · 14,976 followersView post →
R
Rohan
@Rohanburdened · X
@PJ_Tanner_ @DrNeilStone Ok I found these 5 other placebo controlled trials for vaccines, from 2015 to today. Doesnt seem insanely rare or anything.
https://t.co/fY1xV7tw22
https://t.co/UITImfsRDp
https://t.co/g7V8uMHnpy
https://t.co/03bzSJQK2v
https://t.co/rmUU57sHM7
May 5, 2025 · 66 likes · 14 shares · 846 followersView post →
D
DKup
@dkupiecki · X
@MichaGenereau @calleymeans @JillianMichaels Stop listening to RFK Jr and Calley
Your statement is a lie
https://t.co/K9xLF66JTz https://t.co/115qz2sWsC
Apr 11, 2025 · 1 like · 1 share · 781 followersView post →
R
RK
@rekesk · X
Massive lie from RFK Jr bc of course he has no fucking clue.
N Engl J Med 2022;386:531-43. DOI: 10.1056/NEJMoa2116185 https://t.co/dqIIJtlfzA https://t.co/99kXgq5eIw
@aintbuyindat @RetroAgent12 @wmdwfprez Of COURSE there were large scale trials, as there always are for vaccines. This is common knowledge. Here's the scientific journal article about the clinical trial of one of them: https://t.co/b54GV2uwAU
@PaulKingsley7 Great Q. This is from the original RCT. In a good problem to have, only 14 of the 20,000 vaccinated individuals were infected (efficacy >90%), of which only 11 had viral load data for this analysis.
No direct comparison is made to Moderna in the study.
https://t.co/oM3Ca1b1Xi
@NuritBaytch How quickly did your serious side-effects begin @NuritBaytch? Are the side-effects now gone?
Did you get the Novavax that got approval, or placebo, or a bigger dose than was approved? Was it this trial?
https://t.co/OpUopeFEGo
two doses of NVX-CoV2373 or placebo 21 days apart.
@AGRothenpieler @JeromeAdamsMD @US_FDA Yes. https://t.co/cLWBNs6gBc Though only single-blinded, it appears, because participants requested unblinding sothey ould get a real vaccine if they'd gotten placebo. (The updated version is the same vaccine, just with a different viral sequence, like an annual flu shot we've
Jun 19, 2024 · 7 shares · 1,212 followersView post →
RJ
REAL Dr. Vicki Coyle, DNP, MSN, RN, JD
@VickiCoyle10019 · X
@stephan19573 @ShaneCook10 @thatsnotmine125 @reignitedemaust EVERY vaccine for COVID is NOT experimental
If experimental, they wouldn't have completed Phase III Clinical Trials
Pfizer: https://t.co/C81XkLdcHk
Moderna: https://t.co/6uEb9jYLjZ
J&J: https://t.co/2NVSUgLYpQ
https://t.co/hHgaDLBGOC
Novavax : https://t.co/6UqfhSljcV
@Kerbrech @DonEford I correct you. You are wrong.
Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico
https://t.co/IQs6XsRLSa
Safety, Immunogenicity, and Efficacy of the NVX-CoV2373 COVID-19 Vaccine in Adolescents
https://t.co/QmN7bAIDIP
@stewak2 @OldIronsights @mblair @VanessaCariddi Here you go, Skippy. All you had to do was google it:
“Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico”
N Engl J Med 2022;386:531-543
https://t.co/guwWjypZb8
$NVAX https://t.co/tnR2x41DEg
@jimiuorio And re: the updated Novavax vaccine. Now simply move the goalposts/your definitions again. I pointed out how pseudo critics - such as McCullough and Malone - do that, & shared a video to help you on that. I'm guessing you didn't watch, though.
https://t.co/1af6Tl0joV https://t.co/V1boRf2mlk
@JoshuaGaspar @Debunk_the_Funk @rozoveanu All of the clinical trial data is published, you could look it up yourself if you cared to. Here are links to a few: https://t.co/8cWQVAC0Jm
https://t.co/A8H2R3P7RU https://t.co/s8LNYQ0dbI
https://t.co/pPLMNi3rIu
https://t.co/b54GV2uwAU
https://t.co/alSDevUjMY
@WayneWi70815642 @antidamage @FrontierNZmedia @c_plushie @dbseymour @SeanPlunket Here is one. But why wouldn't you Google it yourself, if you were genuinely interested?
https://t.co/WceTttYmbS
@SararaSarava Literalmente TODAS as vacinas tem ensaios clínicos randomizados pré-aprovação.
https://t.co/p6t832k20z
https://t.co/py0AGUMV3e
https://t.co/SqUn4CRQ5u
Esses foram os iniciais, depois seguiram muitos.
@UnMaskd_Truth @CBoy287 @VPrasadMDMPH Dunkle LM, Kotloff KL, Gay CL, et al. Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico. N Engl J Med 2022; 386:531.
RT @Jikkyleaks: @MarkC_LVB @FluoridePoison @karrichapus @canceledmouse The assumption from this paper is that the study could be fraudulent…
Jan 25, 2024 · 8 shares · 713 followersView post →
V
virgo
@virgotopia · X
RT @FluoridePoison: Novavax shareholder currently wasting my time promoting the
Jan 24, 2024 · 13 shares · 159 followersView post →
SG
Shill Gates
@drob256 · X
RT @Jikkyleaks: @MarkC_LVB @FluoridePoison @karrichapus @canceledmouse The assumption from this paper is that the study could be fraudulent…
Jan 24, 2024 · 8 shares · 2,083 followersView post →
CH
Call Out the Holy Names & Be Happy
@Ch4ntHareKrsna · X
RT @Jikkyleaks: @MarkC_LVB @FluoridePoison @karrichapus @canceledmouse The assumption from this paper is that the study could be fraudulent…
Jan 24, 2024 · 8 shares · 1,132 followersView post →
MB
Matthew B
@Wontevertweet27 · X
RT @Jikkyleaks: @MarkC_LVB @FluoridePoison @karrichapus @canceledmouse The assumption from this paper is that the study could be fraudulent…
Jan 24, 2024 · 8 shares · 1,950 followersView post →
HB
Hope Larkin-Begley
@HopeBegley · X
RT @FluoridePoison: Novavax shareholder currently wasting my time promoting the
Jan 24, 2024 · 13 shares · 2,741 followersView post →
AA
Andy D’Alessio
@sash_andy · X
RT @FluoridePoison: Novavax shareholder currently wasting my time promoting the
Jan 24, 2024 · 13 shares · 3,954 followersView post →
K
KAS
@KAS753040428370 · X
RT @Jikkyleaks: @MarkC_LVB @FluoridePoison @karrichapus @canceledmouse The assumption from this paper is that the study could be fraudulent…
Jan 24, 2024 · 8 shares · 154 followersView post →
BB
Blusey Blue
@blusey_blue · X
RT @Jikkyleaks: @MarkC_LVB @FluoridePoison @karrichapus @canceledmouse The assumption from this paper is that the study could be fraudulent…
Jan 24, 2024 · 8 shares · 443 followersView post →
GP
Geoffrey Norman Pain
@FluoridePoison · X
RT @Jikkyleaks: @MarkC_LVB @FluoridePoison @karrichapus @canceledmouse The assumption from this paper is that the study could be fraudulent…
Jan 24, 2024 · 8 shares · 8,455 followersView post →
JF
Julie Fish
@fishdippers · X
RT @FluoridePoison: Novavax shareholder currently wasting my time promoting the
Jan 24, 2024 · 13 shares · 1,473 followersView post →
JC
Jurassic Carl
@carl_jurassic · X
RT @FluoridePoison: Novavax shareholder currently wasting my time promoting the
Jan 24, 2024 · 13 shares · 8,721 followersView post →
PS
Pasi Suominen
@pasiz · X
RT @Jikkyleaks: @MarkC_LVB @FluoridePoison @karrichapus @canceledmouse The assumption from this paper is that the study could be fraudulent…
Jan 24, 2024 · 8 shares · 2,930 followersView post →
J
Jikkyleaks
@Jikkyleaks · X
@MarkC_LVB @FluoridePoison @karrichapus @canceledmouse The assumption from this paper is that the study could be fraudulent because the authors misrepresented their data sharing statement.
They claimed to @NEJM they will share the data and the link goes to "No IPD data sharing"
The data now needs audit.
https://t.co/PXmfEusFWo https://t.co/mQtO1MJfkO
Jan 24, 2024 · 18 likes · 8 shares · 112,971 followersView post →
MC
Mark C
@MarkC_LVB · X
@Jikkyleaks @FluoridePoison @karrichapus @canceledmouse Referring to the study in the link from the New England Journal of medicine.
https://t.co/PpEi9cTZlL
RT @FluoridePoison: Novavax shareholder currently wasting my time promoting the
Jan 20, 2024 · 13 shares · 109 followersView post →
TN
The Notebook
@karrichapus · X
RT @FluoridePoison: Novavax shareholder currently wasting my time promoting the
Jan 19, 2024 · 13 shares · 5,948 followersView post →
HG
Hans Christian Andersen‘s GHOST!
@HansChr52239198 · X
RT @FluoridePoison: Novavax shareholder currently wasting my time promoting the
Jan 19, 2024 · 13 shares · 2,090 followersView post →
H
1howyoudoin
@1howudoin · X
RT @FluoridePoison: Novavax shareholder currently wasting my time promoting the
Jan 19, 2024 · 13 shares · 1,550 followersView post →
D
digby1
@digby1 · X
RT @FluoridePoison: Novavax shareholder currently wasting my time promoting the
Jan 19, 2024 · 13 shares · 1,861 followersView post →
P
pmcd
@pmcdunnough · X
RT @FluoridePoison: Novavax shareholder currently wasting my time promoting the
Jan 19, 2024 · 13 shares · 13,288 followersView post →
L
Lancillotto
@Lancillotto810 · X
RT @FluoridePoison: Novavax shareholder currently wasting my time promoting the
Jan 19, 2024 · 13 shares · 256 followersView post →
S
Shane
@Shane04488381 · X
RT @FluoridePoison: Novavax shareholder currently wasting my time promoting the
Jan 19, 2024 · 13 shares · 1,191 followersView post →
GP
Geoffrey Norman Pain
@FluoridePoison · X
Novavax shareholder currently wasting my time promoting the
Jan 19, 2024 · 49 likes · 13 shares · 8,455 followersView post →
M
MarilynFrench07
@MarilynFrench07 · X
RT @DrAliSKhan: @FasoleMio @murphy_ld @CallMePye45 90% effective overall against lab-confirmed, symptomatic infection. And if you are not i…
Jan 6, 2024 · 1 share · 2,107 followersView post →
DK
Dr. Ali Khan
@DrAliSKhan · X
@FasoleMio @murphy_ld @CallMePye45 90% effective overall against lab-confirmed, symptomatic infection. And if you are not infected, you can not transmit the disease.
https://t.co/JIY5GQhqRo
Jan 5, 2024 · 8 likes · 1 share · 14,514 followersView post →
@Leviathan_100 @TakethatCt @liedsuddenly @The__D__Ry Pfizer: 43,448 people https://t.co/noVU8gLkJl
Moderna: 30,420 people https://t.co/LIhxOCqdKO
Novavax: 15,187 people in the UK, 29,582 in the US and Mexico
https://t.co/Z4N7la96gg
https://t.co/6E9YSACS6z
@nzdsos And if you don't like mRNA
Here is one for Novavax
Do you actually provide any research - no you lot only provide opinions and stories for emotional appeal
That's not science
https://t.co/F4kYSL2zgq
RT @RogerSeheult: How is Novavax different from the mRNA vaccines.
A good review:
Novavax Explained Clearly
https://t.co/Ql1SpRXKC7
Nov 4, 2023 · 5 shares · 1,123 followersView post →
BW
Bill Walker
@BWalkerTTAGGG · X
RT @RogerSeheult: How is Novavax different from the mRNA vaccines.
A good review:
Novavax Explained Clearly
https://t.co/Ql1SpRXKC7
Nov 4, 2023 · 5 shares · 1,424 followersView post →
LR
(((Liz Ditz))). Mask up, y'all. Viruses are real.
@lizditz · X
RT @RogerSeheult: How is Novavax different from the mRNA vaccines.
A good review:
Novavax Explained Clearly
https://t.co/Ql1SpRXKC7
Nov 4, 2023 · 5 shares · 10,468 followersView post →
RM
Roger Seheult, MD
@RogerSeheult · X
How is Novavax different from the mRNA vaccines.
A good review:
Novavax Explained Clearly
https://t.co/Ql1SpRXKC7
Nov 4, 2023 · 35 likes · 5 shares · 28,028 followersView post →
LS
Lance Stenftenagel
@A1persona · X
@Silver_Lining76 @BDudovich @JeromeAdamsMD It was 90% effective in this study: "These results yielded a vaccine efficacy of 90.4%"
https://t.co/7nPidHoH6a
@SocialFuzzer @mildanalyst Thank you for sharing. I was going off data during trial. Such events were not detected during mRNA trials but were for novavax (although they were looking for it in nova). The adverse events section is at the end and they are quite rare, but detected. https://t.co/8yjifQ8nym https://t.co/aK1M5IomQR
Sep 13, 2022 · 1 like · 6,213 followersView post →
T
Tina
@TinaPfeiffer10 · X
Novavax Explained Clearly https://t.co/O1dJOARYl2 via @YouTube
@shravaka Novavax trial conducted in first half of 2021, previous variants. Median follow up participants was only 2 months. After 3 -4 months participants unblinded & given vax, removing control group. As with all the vax trials, too short, biased.
https://t.co/7Z9WU2cVUy
RT @BanounHelene: Ces données n'apparaissaient pas dans la publication !
https://t.co/frKJuEWdxd
Efficacy and Safety of NVX-CoV2373 in Adu…
Jun 5, 2022 · 21 shares · 2,272 followersView post →
JJ
joss joss
@jossjossjoss001 · X
@BanounHelene Un point important que Michel de Lorgeril avait relevé, c'est que dans l'étude Novavax (comme dans les autres d'ailleurs), on parle de "observer-blinded" et non de "double-blind"-> donc pas de double aveugle.
https://t.co/ca8zKxgjRl
DOI: 10.1056/NEJMoa2116185
RT @BanounHelene: Novavax Myocardites
FDA Novavax juin 2022
Ces données n'apparaissaient pas dans la publication !
Efficacy and Safety of N…
Jun 4, 2022 · 13 shares · 610 followersView post →
P
Paysanne71
@paysanne71 · X
RT @BanounHelene: Ces données n'apparaissaient pas dans la publication !
https://t.co/frKJuEWdxd
Efficacy and Safety of NVX-CoV2373 in Adu…
Jun 4, 2022 · 21 shares · 351 followersView post →
P
Paysanne71
@paysanne71 · X
RT @BanounHelene: Novavax Myocardites
FDA Novavax juin 2022
Ces données n'apparaissaient pas dans la publication !
Efficacy and Safety of N…
Jun 4, 2022 · 13 shares · 351 followersView post →
LH
Labeyrie Hélène
@Conneriephobe56 · X
RT @BanounHelene: Novavax Myocardites
FDA Novavax juin 2022
Ces données n'apparaissaient pas dans la publication !
Efficacy and Safety of N…
Jun 4, 2022 · 13 shares · 1,530 followersView post →
TP
Thibault Pillet
@thibaultpillet · X
RT @BanounHelene: Ces données n'apparaissaient pas dans la publication !
https://t.co/frKJuEWdxd
Efficacy and Safety of NVX-CoV2373 in Adu…
Jun 4, 2022 · 21 shares · 2,358 followersView post →
HB
Hélène Banoun
@BanounHelene · X
Novavax Myocardites
FDA Novavax juin 2022
Ces données n'apparaissaient pas dans la publication !
Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico
Rapport complet ici
https://t.co/fFA21SOxGG
Jun 4, 2022 · 31 likes · 13 shares · 84,700 followersView post →
LF
lou f
@louf57683615 · X
RT @BanounHelene: Ces données n'apparaissaient pas dans la publication !
https://t.co/frKJuEWdxd
Efficacy and Safety of NVX-CoV2373 in Adu…
Jun 4, 2022 · 21 shares · 342 followersView post →
HB
Hélène Banoun
@BanounHelene · X
Ces données n'apparaissaient pas dans la publication !
https://t.co/frKJuEWdxd
Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico
Jun 4, 2022 · 46 likes · 21 shares · 84,700 followersView post →
May 27, 2022 · 3 likes · 4,734 followersView post →
JO
James William Owens
@Willard1951 · X
@Jaytee116James @mcfunny @lazlowoodbine42 @AndrewLazarus4 @AspAlaAsnAsnTyr @AlBowers1 @JonathanHannah @ogilville1 @FvckYourFear @krebiozen @mpc_xetts @ShockTraumaRN @volpiranyas @JamesLynchGTC @andylumm @dann58638436 @djchicus @richykirsh @provaxtexan @JimeeLiberty @SkepticalMutant @TonyBaduy @doom37455413 @msabouri @Alex_on_A14 @isthisnetaken @PremierImproves @malo_j @Tryingmypatient @chimera414 @itisjustmebabe @WalterTAllen @Diar380 @realshocks @kath2cats @756Elizabeth @skepticalprune @ShockTraumaNP @kcgetaway7 @RandomUrban @WendyOrent @Nockit1 @pompili_amanda @ZaynJaffer @PLHartungRN @raouldukeerik @spoonsterboss1 @PiattPicks @Fannyi5 @sammy44231 Another vaccine technology, recently approved in Canada, is under FDA review
Novavax is one of the recombinant spike protein vaccines
Has some advantages
Phase 3 looks good https://t.co/qR5uL2rMol ; issue may be manufacturing which held up Mo
RT @carpe_diem0820: 北米で実施されたノババックスのアジュバント入り蛋白サブユニットCOVID-19ワクチンの第3相試験の結果
感染予防効果は90.4％、中等度-重症予防効果は100％
接種は昨年12月～今年2月
Efficacy and Safety of…
May 11, 2022 · 8 shares · 161 followersView post →
DP
Dogs for Object Permanence
@B_Dogs4 · X
Then published in NEJM: Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico
For @DevilvTheDeepB1
https://t.co/uw6k7KpGJg
Trial included people with stable chronic health conditions. I do not *believe* but would take a fact check on the others doing that.
Apr 21, 2022 · 1 like · 4,344 followersView post →
ド
ドンマッツ
@DonMatz1959 · X
メモ
Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico | medRxiv https://t.co/BoqgmsayFA
@ModSlotPro @Marc_Veld @TWenseleers @TijlDeBie @ErikCumps @HarrySpoelstra @SchoofsLiliane @lfoquet @sigridschollen @R137K @GeelenJoris @Jean__Fisch @tbuytaer @Celine_student @peter_persyn @DominiekC Deze
"Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico"
https://t.co/EQQ15tuAun
Deze
"Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant"
https://t.co/ITZniZ2PMJ
En
2/3
@MvE_Politiek @Marc_Veld @ErikCosters @SjefVugt schaal toegepast wordt.
Dit is nog een andere publicatie over Novavax.
"Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico"
https://t.co/EQQ15tuAun
2/2
Mar 24, 2022 · 4 likes · 1,498 followersView post →
AA
AlainCo #JeSuisPrometheen e/acc
@alain_co · X
RT @Locuste_: Le premier essai fut conduit au Mexique et aux États-Unis sur 30 000 personnes, en plein essor du variant Alpha.
Verdict : 9…
Mar 13, 2022 · 1 share · 3,338 followersView post →
X
Xxi
@Locuste_ · X
Le premier essai fut conduit au Mexique et aux États-Unis sur 30 000 personnes, en plein essor du variant Alpha.
Verdict : 90,4% de protection contre les formes symptomatiques, et 100% contre les formes sévères.
https://t.co/aGGukZ52tS
Mar 13, 2022 · 19 likes · 1 share · 10,825 followersView post →
S
Sharon
@SharonandGlenn · X
@BigDoucheGolfer @JCCFCanada Have a look at Supplementary Appendix to https://t.co/b5MsT1tiIm
Feb 24, 2022 · 9 shares · 1,011 followersView post →
F
Flav
@Flavr7 · X
RT @Giandom84354994: BMJ su Novavax
Feb 23, 2022 · 9 shares · 866 followersView post →
VB
Valerio Brinato
@Valerio_Brinato · X
RT @Giandom84354994: BMJ su Novavax
Feb 23, 2022 · 9 shares · 439 followersView post →
NK
Nasty_kia
@ChiaraLocatell7 · X
RT @Giandom84354994: BMJ su Novavax
Feb 23, 2022 · 9 shares · 288 followersView post →
Z
ZioKlint
@ZioKlint · X
RT @Giandom84354994: BMJ su Novavax
Feb 23, 2022 · 9 shares · 12,850 followersView post →
NC
Nessuna Correlazione
@NessunaCorrelaz · X
RT @Giandom84354994: BMJ su Novavax
Feb 23, 2022 · 9 shares · 5,517 followersView post →
EN
Ele.na
@elena6580 · X
RT @Giandom84354994: BMJ su Novavax
Feb 23, 2022 · 9 shares · 738 followersView post →
KZ
K2 Zed
@K274863601 · X
RT @Giandom84354994: BMJ su Novavax
Feb 23, 2022 · 9 shares · 1,759 followersView post →
U
Unvaccinated
@NonVaccinato · X
RT @Giandom84354994: BMJ su Novavax
Feb 23, 2022 · 9 shares · 3,749 followersView post →
G
Giandomenico
@Giandom84354994 · X
BMJ su Novavax
Feb 23, 2022 · 18 likes · 9 shares · 7,409 followersView post →
DW
Dr. Alexander Wong
@awong37 · X
2 large clinical trials form the basis for the approval.
The first involved nearly 30,000 persons 18+ in US/Mexico given 2 doses mostly w/ Alpha variant.
Persons who received vaccine had a 90.4% reduction symptomatic infection vs. placebo. /4
https://t.co/nNcfywyVNc
Feb 17, 2022 · 5 likes · 16,158 followersView post →
Hⵕ
Hocine Remini, Ph.D "ⵃoⵛⵉⵏⴻ ⵕⴻⵎⵉⵏⵉ"
@HocineRemini · X
Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico | NEJM https://t.co/dOcIK9ZVBE
IDCRC-supported work w/ @Novavax @UMmedschool @NIAIDNews: Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico in @NEJM https://t.co/kiXG4cyu0n #COVID19 #Vaccination #IDResearch
RT @uchida_kawasaki: 米国およびメキシコの成人における NVX-CoV2373 ワクチンの有効性と安全性 ｜ https://t.co/AW6GXs5BD7
Efficacy and Safety of NVX-CoV2373 in Adults in…
Feb 13, 2022 · 1 share · 10,315 followersView post →
内
内田
@uchida_kawasaki · X
米国およびメキシコの成人における NVX-CoV2373 ワクチンの有効性と安全性 ｜ https://t.co/AW6GXs5BD7
Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico | NEJM https://t.co/IVZkNx2sDd
#ノババックス
Feb 13, 2022 · 1 like · 1 share · 1,923 followersView post →
PN
Peter Noone
@PedroNunez · X
Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico | NEJM https://t.co/XCwkZYVdQv
日本語版Abstract
米国およびメキシコの成人における NVX-CoV2373 ワクチンの有効性と安全性
Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico
February 10, 2022 Vol. 386 No. 6
https://t.co/kCbU2AktiP
動画・グラフ・イラスト付き簡易まとめのQuick Take追加
Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico
February 10, 2022
動画
https://t.co/AZcUROrbqw
Finally! Novavax will soon unleash a billion doses of a vaccine that doesn't need to be frozen and is made by very old, proven, safe technology that should shut up those idiots hesitant about mRNA vax. https://t.co/WhaLUKkGAE
Feb 9, 2022 · 2 likes · 1 share · 408 followersView post →
דH
ד״ר אבשלום כרמל ומיסטר הייד Dr carmel & Mr hide
@mdkatrsk · X
Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico https://t.co/vZzWQUBCQZ זה הניסוי של חיסון נוווקס . 90% יעילות קצרת מועד בפני מחלה. מאחר והיו רק 4 מקרים קשים סה"כ אי אפשר להגיד הרבה על אספקט זה (מבחינתם זה 100%)
Feb 6, 2022 · 3 likes · 8,988 followersView post →
OY
Oksana Yonan
@1Truthkeeper · X
COVID VACCINE HESITANT? This is YOUR VACCINE! https://t.co/SDes814eZY via @YouTube
This is the vaccine that I'm going to have because it's not as dangerous as mRNA on people like me
@SarahSevans2000 @MaryRuthWeber2 @SheilaColley
@EFastsaga
https://t.co/3TVB8NzqK7
@shane1901374012 @ellymelly Consider this. The risk of dying or getting long-term health problems from contracting COVID is much higher than not getting a vaccine. Listen to what this doctor has to say. https://t.co/qoGjcailZX
Jan 20, 2022 · 2 likes · 1 share · 385 followersView post →
M
M
@M96191366 · X
@AmethystChew1 @ellymelly Antigen is not from moth, it is from tree. Listen to this https://t.co/qoGjcailZX
RT @DrRebeccaO: Novavax NVX-CoV2373 vaccine approved overseas, when for Australia? #auspol
@NEJM :
• coexisting conditions in 47.3% of par…
Jan 10, 2022 · 7 shares · 3,248 followersView post →
S
Susan
@Susan29191404 · X
RT @DrRebeccaO: Novavax NVX-CoV2373 vaccine approved overseas, when for Australia? #auspol
@NEJM :
• coexisting conditions in 47.3% of par…
Jan 10, 2022 · 7 shares · 1,137 followersView post →
Z
Zera
@zeratul221b · X
@su_ni_pe @RodneyCorbine @Karl_Lauterbach https://t.co/zMfAxcUiUC hier unter supplementary material und dann supplementary appendix
Tabelle zB ab S. 46
RT @DrRebeccaO: Novavax NVX-CoV2373 vaccine approved overseas, when for Australia? #auspol
@NEJM :
• coexisting conditions in 47.3% of par…
Dec 23, 2021 · 7 shares · 4,063 followersView post →
DP
Dr Rebecca Oyomopito (PhD)
@DrRebeccaO · X
RT @DrRebeccaO: Novavax NVX-CoV2373 vaccine approved overseas, when for Australia? #auspol
@NEJM :
• coexisting conditions in 47.3% of par…
Dec 22, 2021 · 7 shares · 1,343 followersView post →
DP
Dr Rebecca Oyomopito (PhD)
@DrRebeccaO · X
Novavax NVX-CoV2373 vaccine approved overseas, when for Australia? #auspol
@NEJM :
• coexisting conditions in 47.3% of participants
• efficacy in preventing moderate-to-severe & symptomatic #COVID19 in those at high risk for acquisition & complications
https://t.co/G4QRY9046J
Dec 22, 2021 · 8 likes · 7 shares · 1,343 followersView post →
P
PEAH
@DanieleDionisio · X
Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico | NEJM https://t.co/D1tKeEWm2z
Dr. Musante was recently published in The New England Journal of Medicine on the Efficacy and Safety of NVX-CoV2373 in Adults in the US and Mexico.
To learn more about M3-Emerging Medical Research and currently enrolling trials, visit our website: https://t.co/rSf1KTzdHG https://t.co/CtiOQ2zs9f
org/doi/pdf/10.1056/NEJMoa2107659?articleTools=tr ue https://www.nejm. org/doi/pdf/10.1056/NEJMoa2116185?articleTools=tr ue Questo vaccino ci dimostra che ...
C
GP
HB
DS
CG
CJ
AB
SS
R
M
DW
S
T
A
MM
VN
PG
A
BN
P
DR
S
AD
LS
TC
D
RB
CL
R
JF
D
A
B
R
MD
W
LC
DP
J
PB
MF
T
RJ
DN
BL
TJ
BN
J
C
TK
SC
VS
LK
FT
V
SG
CH
MB
AA
K
BB
JC
PS
J
MC
BT
TN
HG
H
D
P
L
S
M
DK
R
L
M
EU
E
M
PB
M
TH
およ
YE
G조
FF
JJ
CA
H
AL
HA
R
MA
C
DE
N
CG
OL
M
JI
GV
S
MM
F
D
C
K
LH
TP
F
JO
つ
DP
ド
G
DS
MS
AA
X
S
GA
F
VB
NK
Z
NC
EN
KZ
U
G
DW
Hⵕ
IC
永性
内
PN
TH
F
HV
JF
DV
דH
FG
CR
HH
SW
O
B
B
AD
SM
CH
S
Z
AK
MR
C
B
Q
RZ
MT
GT
DP
P
MF
IS
EG
ER